jRCT2080224807已完成1 期
Phase 1 trial of adrenomedullin: Multiple-dose administration study
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 12
- 试验地点
- 1
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Randomized, Double-blind, Single-center Study
- 主要目的
- Treatment Purpose
入排标准
- 年龄范围
- 20age old over 至 65age old under（—）
- 性别
- Male
入选标准
- •healthy male
排除标准
- •history of malignancy and/or myocardial infarction
- •systolic blood pressure under 100 mmHg
- •pulse rate under 45 bpm
- •body weight over 90 kg
结局指标
主要结局
-
safety safety and tolerability
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Multiple-dose administration study of adrenomedulliJPRN-jRCT2080224807niversity of MIyazaki12
已完成
不适用
A Comparative of high dose and low dose adrenocorticotropic hormone (ACTH) therapy for infantile spasmInfantile spasm.Other generalized epilepsy and epileptic syndromesIRCT2015060110634N2Vice Chancellor for research of Hamedan Univercity of Medical Sciences30
进行中（未招募）
2 期
Adrenomedullin for CADASIJPRN-jRCT2051210117Ihara Masafumi60
已完成
1 期
Continuous intravenous adrenomedullin therapy for patients with inflammatory bowel disease (ulcerative colitis and Crohn's disease)inflammatory bowel disease (ulcerative colitis and Crohn's disease)JPRN-UMIN000021421First Department of Internal Medicine, Faculty of Medicine, University of Miyazaki10
招募中
1 期
Trial of Two Adagrasib Dosing Regimens in NSCLC with KRAS G12C Mutatioon-small cell lung cancerMedDRA version: 21.1Level: PTClassification code: 10059515Term: Non-small cell lung cancer metastatic Class: 100000004864CTIS2023-503523-25-00Mirati Therapeutics Inc.262